Analysis of Circulating Tumor Markers in the Blood (ALCINA)

  • STATUS
    Recruiting
  • End date
    Jan 1, 2025
  • participants needed
    760
  • sponsor
    Institut Curie
Updated on 1 March 2021
tumor markers
anticoagulants
metastasis

Summary

Exploratory study on blood-borne biological markers and their correlation with clinical and pathological characteristics.

Description

Exploratory multi-cohort study including different types of cancer (different organs and/or different histological types).

Each kind of blood-borne biological markers analyses corresponds to a cohort.

Details
Condition Cancer, Cancer/Tumors, Neoplasms, Cancer (Pediatric), Ewing's Family Tumors, Cancer, Cancer/Tumors, Ewing's Family Tumors, Cancer (Pediatric), Neoplasms, primary cancer, primary malignant neoplasm, malignancy, cancers, malignancies, malignant tumor, malignant tumors
Treatment blood sampling, Tumor sampling, Stool sampling
Clinical Study IdentifierNCT02866149
SponsorInstitut Curie
Last Modified on1 March 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patient with any tumoral disease (proven or suspected), of any type and stage
More than18 years old
Signed informed consent form
Additional inclusion criteria if a tumor sample is needed
\. Tumor considered as accessible by biopsy
\. Normal blood coagulation tests on the last blood analysis
Non-inclusion Criteria
Patient in detention or protected by the law
Patient who cannot comply with the study follow up for geographical, social or psychological reasons
Additional non-inclusion criteria if a tumor sample is needed
\. Anticoagulant or antiaggregant that cannot be interrupted for the biopsy
\. central-nervous system metastases only (unless a diagnostic or curative
surgery is planned before the inclusion in the study)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note